272 related articles for article (PubMed ID: 29512164)
1. Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody.
Phung TV; Houfflin-Debarge V; Ramdane N; Ghesquière L; Delsalle A; Coulon C; Subtil D; Vaast P; Garabedian C
Transfusion; 2018 May; 58(5):1199-1205. PubMed ID: 29512164
[TBL] [Abstract][Full Text] [Related]
2. Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
Vlachodimitropoulou E; Garbowski M; Anne Solomon S; Abbasi N; Seaward G; Windrim R; Keunen J; Kelly E; Van Mieghem T; Shehata N; Ryan G
Br J Haematol; 2022 Feb; 196(4):1096-1104. PubMed ID: 34862601
[TBL] [Abstract][Full Text] [Related]
3. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation.
Walsh CA; Russell N; McAuliffe FM; Higgins S; Mahony R; Carroll S; McParland P
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):235-9. PubMed ID: 24075591
[TBL] [Abstract][Full Text] [Related]
4. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
Dodd JM; Andersen C; Dickinson JE; Louise J; Deussen A; Grivell RM; Voto L; Kilby MD; Windrim R; Ryan G;
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
[TBL] [Abstract][Full Text] [Related]
5. Management of red blood cell alloimmunization in pregnancy.
Ghesquière L; Garabedian C; Coulon C; Verpillat P; Rakza T; Wibaut B; Delsalle A; Subtil D; Vaast P; Debarge V
J Gynecol Obstet Hum Reprod; 2018 May; 47(5):197-204. PubMed ID: 29476829
[TBL] [Abstract][Full Text] [Related]
6. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
[TBL] [Abstract][Full Text] [Related]
7. [Follow-up of pregnancies with red-cell allo-immunisation: State-of-the art].
Carbonne B; Castaigne V; Cynober E; Levy R; Cortey A; Mailloux A; Larsen M; Brossard Y
Gynecol Obstet Fertil; 2010 Mar; 38(3):205-13. PubMed ID: 20207183
[TBL] [Abstract][Full Text] [Related]
8. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
9. Relationship between obstetric history and Rh(D) alloimmunization severity.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
[TBL] [Abstract][Full Text] [Related]
10. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
Babinszki A; Lapinski RH; Berkowitz RL
Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
[TBL] [Abstract][Full Text] [Related]
12. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
13. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?
Chitkara U; Bussel J; Alvarez M; Lynch L; Meisel RL; Berkowitz RL
Obstet Gynecol; 1990 Oct; 76(4):703-8. PubMed ID: 2120641
[TBL] [Abstract][Full Text] [Related]
14. [Foetal-maternal alloimmunizations in the South-East area of the Venice province].
Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F
Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866
[TBL] [Abstract][Full Text] [Related]
15. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
[TBL] [Abstract][Full Text] [Related]
16. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
[TBL] [Abstract][Full Text] [Related]
17. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
[TBL] [Abstract][Full Text] [Related]
18. Management of rhesus alloimmunization in pregnancy.
Moise KJ
Obstet Gynecol; 2008 Jul; 112(1):164-76. PubMed ID: 18591322
[TBL] [Abstract][Full Text] [Related]
19. Management and prevention of red cell alloimmunization in pregnancy: a systematic review.
Moise KJ; Argoti PS
Obstet Gynecol; 2012 Nov; 120(5):1132-9. PubMed ID: 23090532
[TBL] [Abstract][Full Text] [Related]
20. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
